Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...
In the global contest for critical raw materials, gallium has emerged as a test of industrial sovereignty. The lightweight metal, essential for semiconductors, LED lighting and defence technologies, ...
With outstanding customization options, an epic sensor, wireless connectivity, and stunningly lightweight, the Pathfinder is exemplary. Really, it's only mildly let down by its price and the fact that ...
Add articles to your saved list and come back to them any time. Critica Limited has identified a secondary high-value opportunity within its flagship Jupiter clay-hosted rare earths deposit near Mt ...
China has suspended a ban on approving exports of “dual-use items” related to gallium, germanium, antimony, and super-hard materials to the U.S., the Commerce Ministry said on Sunday (November 9, 2025 ...
China has lifted a nearly year-long ban on exports of gallium, germanium and antimony to the US, in a further de-escalation of trade tensions between the world’s two largest economies. In a statement ...
Alcoa (NYSE:AA) said Monday it is set to collaborate with the U.S. and Australian governments to advance the development of a new gallium plant to be co-located at the company’s Wagerup alumina ...
SEOUL, Oct. 20 (UPI) --Non-ferrous metal giant Korea Zinc said it plans to build a gallium recovery facility in the country to manufacture the critical raw material beginning in 2028. Toward that end, ...
INDIANAPOLIS -- Indianapolis Colts backup quarterback Anthony Richardson suffered an orbital fracture to his eye prior to Sunday's 31-27 victory over the Arizona Cardinals, according to coach Shane ...
Bristol Myers Squibb (NYSE:BMY) has agreed to acquire privately held biotechnology company Orbital Therapeutics for $1.5 billion in cash. Orbital Therapeutics is advancing a new generation of RNA ...
The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing deeper into in vivo cell therapies, BMS has agreed to pay $1.5 billion to buy the biotech for a pipeline led by a ...
Francesco Cacciatore is a self-proclaimed skeptic. Yet after spending two decades in the European aerospace industry and hitting, as he put it, a “crisis,” he made an undeniably optimistic bet: He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback